Loading...
In a randomized trial published in 2001, Belgian researchers demonstrated that intensive insulin therapy lowered mortality among hyperglycemic surgical intensive care unit patients, most of whom had undergone cardiac surgery (Journal Watch Nov 16 2001). Now these researchers have conducted a similar randomized trial in their medical ICU.
Twelve hundred patients with anticipated ICU stays ≥3 days received either “conventional” insulin treatment (continuous infusion started when glucose exceeds 215 mg/dL and adjusted to maintain blood glucose at 180–200 mg/dL) or intensive insulin treatment (infusion started when glucose exceeds 110 mg/dL and adjusted to maintain glucose at 80–110 mg/dL). About 17% had known diabetes.
The primary endpoint, in-h…